Filing Details
- Accession Number:
- 0001225208-11-013130
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-05-04 14:57:21
- Reporting Period:
- 2011-05-02
- Filing Date:
- 2011-05-04
- Accepted Time:
- 2011-05-04 14:57:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 901219 | Human Genome Sciences Inc | HGSI | Biological Products, (No Disgnostic Substances) (2836) | 223178468 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1191231 | H James Davis | 14200 Shady Grove Road Rockville MD 20850 | Exec. Vp, Gen Counsel & Sec. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-05-02 | 8,653 | $0.52 | 97,392 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-05-02 | 8,653 | $30.00 | 88,739 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option - Right to Buy | Disposition | 2011-05-02 | 8,653 | $0.00 | 8,653 | $0.52 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 141,347 | 2019-03-10 | No | 4 | M | Direct |
Footnotes
- The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and Charles Schwab effective May 2, 2011.
- One-eighth of the 150,000 options granted on March 10, 2009, vested on the six-month anniversary date (September, 2009) and the remaining options granted vested and continue to vest monthly on a ratable basis for the next 42 months commencing on October 10, 2009.
Billionaire Hedge Funds
